arrow
K

Konstantinos Koutsoukos

athens medical school
H指数:18
被引数:940

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nivolumab plus chemoradiotherapy in patients with non-metastatic muscle-invasive bladder cancer (nmMIBC), not undergoing cystectomy: A phase II, randomized study by the Hellenic GU Cancer Group

纳武利尤单抗联合放化疗在未行根治性膀胱切除术的非转移性肌层浸润性膀胱癌(nmMIBC)患者中的应用:一项由希腊GU癌症研究组开展的II期随机研究

2024-09-011
PRE
SARS-CoV-2 neutralizing antibodies after first vaccination dose in breast cancer patients receiving CDK4/6 inhibitors

接受CDK4/6抑制剂的乳腺癌患者首次接种疫苗后SARS-CoV-2中和抗体

BREAST
IF7.9
2021-12-0115
OAAI
Treatment with abiraterone or enzalutamide does not impair immunological response to COVID-19 vaccination in prostate cancer patients
2021-10-096
OAAI
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome-Results from the International Metastatic Renal Cell Carcinoma Database Consortium

同步与异时转移性疾病: 转移时间对患者预后的影响-国际转移性肾细胞癌数据库联盟的结果

2020-08-0131
OAAI
Efficacy and safety of the combination of bevacizumab (BEV) and temsirolimus (TEM) in patients with metastatic renal cancer (mRCC) after first-line anti-VEGF treatment: A Hellenic Cooperative Oncology group (HeCOG) phase II trial

贝伐单抗 (BEV) 和替西罗莫司 (TEM) 联合一线抗VEGF治疗后转移性肾癌 (mRCC) 患者的疗效和安全性: 希腊肿瘤协作组 (HeCOG) II期试验

2016-10-010
OAAI